Sort by
Refine Your Search
-
Listed
-
Employer
- UNIVERSITA' TELEMATICA SAN RAFFAELE ROMA S.R.L.
- Università degli Studi di Brescia
- ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA - - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
- CNR - ISTITUTO DI CRISTALLOGRAFIA (IC)
- ISTITUTO ITALIANO DI TECNOLOGIA
- Università degli Studi di Ferrara
- Università degli Studi di Pavia
- Università degli Studi di Perugia
-
Field
-
to their effectiveness especially in the context of chronic non-communicable diseases of systems such as the cardiovascular, nervous, immune and metabolic ones. Furthermore, the synergism between pharmacological and
-
13 Apr 2024 Job Information Organisation/Company Università degli Studi di Ferrara Research Field Pharmacological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First
-
Generation EU Reference Number Avviso di selezione n° IC_010_2024_BA Is the Job related to staff position within a Research Infrastructure? No Offer Description Project "Pharmacological Chaperon Therapy
-
ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA - - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE | Italy | 1 day ago
Pharmacological sciences » Clinical pharmacology Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Country Italy Application Deadline 17
-
to magnetic fields) or pharmacological stimuli in transgenic animals. The candidate must demonstrate a solid knowledge of the basics of cellular biology and biophysics also in relation to pathological states
-
23 Mar 2024 Job Information Organisation/Company Università degli Studi di Perugia Research Field Pharmacological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First
-
4 Apr 2024 Job Information Organisation/Company Università degli Studi di Pavia Research Field Pharmacological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First
-
pharmacology. In the clinical-care setting, the candidate will carry out his/her activity in long-term care and outpatient settings. Type of commitment: The candidate is required to make a full-time commitment
-
the electrical activity of human cells and their response to external stimuli. In particular, we aim to conceive effective approaches for pharmacological screenings and for evaluating neurotoxicity and
-
, the transplant area with the use of haematopoietic stem cells (HSC) and immunotherapym pharmacological and with monoclonal antibodies and CAR-T cells, both for the treatment of onco-haematological disesases and